申请人:Merck & Co., Inc.
公开号:US05401745A1
公开(公告)日:1995-03-28
Phenoxyphenylacetic acids and derivatives of general structural formula I ##STR1## have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebal and cardiac ischemia, myocardial infarction, inflammatory diseases, Raynaud's disease, and endotoxic shock, and asthma.
苯氧基苯乙酸及其一般结构式I的衍生物 ##STR1## 具有内皮素拮抗剂活性,因此在治疗心血管疾病方面具有用处,例如高血压、缺血后肾衰竭、血管痉挛、脑和心脏缺血、心肌梗死、炎症性疾病、雷诺氏病、内毒素性休克和哮喘。